Dr. Jonathan David Kaplan, MD

Dr. Kaplan practices at The Outpatient Center of Delray in Delray Beach, Florida.

Dr. Kaplan's NPI, 1255327284, was assigned on September 26, 2005. Dr. Kaplan graduated from SUNY Downstate Health Sciences University in 1986. Dr. Kaplan holds Florida license 66479.

Dr. Kaplan's primary practice is The Outpatient Center of Delray, at 4675 Linton Blvd, Delray Beach, FL 33445. The practice phone is (561) 499-9585.

Dr. Kaplan's primary practice is The Outpatient Center of Delray in Delray Beach, Florida. Dr. Kaplan is also affiliated with Delray Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Kaplan to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kaplan is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Kaplan is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Kaplan treats.

CMS data shows 7,535 Medicare services from Dr. Kaplan across 23 procedure codes in 2024, for 723 Medicare patients. Medicare paid $254,730 for them.

CMS counts 723 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 75 to 84, with 307 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 67, with 54% women.

In 2024, Dr. Kaplan wrote 1,451 Medicare Part D claims for 641 patients. 75% of them were for generic drugs. CMS names the drug for 1,286 of them, across 26 drugs with 11 or more claims each, at $697,614 in total drug cost. In 2023, CMS named 1,276 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kaplan for performance year 2024, reported as part of a group. Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaplan as offering telehealth. CMS counts 159 procedures of colonoscopy by Dr. Kaplan, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,415 general payments to Dr. Kaplan from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $5,987.

Dmand AI lists 1 award for Dr. Kaplan, most recently CMS Stage 1 2012 in 2012.

Dr. Kaplan graduated from SUNY Downstate Health Sciences University in 1986.

Dr. Kaplan is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.